Airflow obstruction that is not fully reversible. It's characterised by persistent respiratory symptoms and airflow limitation due to alveolar abnormalities usually caused by exposure to noxious particles or gases.
Risks
Smoking
Noxious gas exposure
Pollution
Occupational dusts and chemicals
Reoccurring infections
Genetic predisposition
Reduced lung growth
Airway hyper-responsiveness
In high-middle income countries, tobacco smoke is the biggest risk for COPD
In low-income counties, exposure to indoor air pollution (biomass and coal fuels for cooking and heating) is the biggest risk for COPD
Symptoms
Chronic cough
Sputum production
Dyspnoea
A history of risks
Diagnostics
Spirometry
FEV is less than or equal to 80%
FEV1/FVC is less than 0.7
Examination
Management
Smoking reduction
Inhaler therapy
Oxygen therapy
Pulmonary rehab
Vaccines
Sputum clearance
Nutritional factors
Advice and educate
Aims of management
Prevent disease progression
Relieve symptoms
Improve exercise tolerance
Improve health status
Prevent and treat complications
Prevent and treat exacerbations
Reduce mortality
Chronic bronchitis
Inflammation and mucous hypersecretion in the large airways
Emphysema
Destruction of the lung parenchyma (respiratory bronchioles)
Small airway disease
Inflation and fibrosis of small airways
Other complications
Weight loss
Skeletal muscle dysfunction
Cardiac dysfunction
Assessment of severity
Spirometry is used to assess the degree of obstruction, but it does not reflect the patient's functional capacity or quality of life.
Exercise testing can be used to evaluate functional capacity and identify patients at risk of adverse events during rehabilitation programs.
Arterial blood gas analysis may be necessary if there are concerns about hypoxemia or hypercapnia.